CMS Backs Away From Expanding Carotid Stenting Coverage

CMS has reversed its earlier proposal to significantly expand coverage of carotid stenting, dampening industry's hopes for a more open U.S. carotid stent market in the near term

More from Archive

More from Medtech Insight